½ÃÀ庸°í¼
»óÇ°ÄÚµå
1507766
¼¼°èÀÇ Á¤¹Ð Áø´Ü ½ÃÀå : ±Ô¸ðº°, À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)Global Precision Diagnostics Market Size study, by Type (Genetic Tests, Esoteric Tests, Others) by Application (Oncology, Cardiovascular, Neurology, Others) by End User (Hospitals, Clinical Laboratories, Homecare) and Regional Forecasts 2022-2032 |
¼¼°è Á¤¹Ð Áø´Ü ½ÃÀåÀº 2023³â¿¡ ¾à 758¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2032³â¿¡ °ÉÃÄ 13.10% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
Á¤¹Ð Áø´ÜÇÐÀº ȯÀÚÀÇ Áúº´ÀÇ Æ¯Á¤ ¿øÀΰú ¼ºÁúÀ» Á¤È®ÇÏ°Ô È®ÀÎÇϱâ À§ÇØ °í±Þ ±â¼úÀ» ÀÌ¿ëÇÏ´Â ÀÇ·á Áø´ÜÇÐ ºÐ¾ß¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº Áø´Ü ±â¼úÀ» °³º° ȯÀÚÀÇ Æ¯¼º¿¡ ¸Â°Ô Á¶Á¤ÇÏ´Â °ÍÀ¸·Î, Á¾Á¾ ´õ Á¤È®ÇÑ Áø´ÜÀ» ´Þ¼ºÇϱâ À§ÇØ À¯ÀüÀÚ, ºÐÀÚ ¹× ¼¼Æ÷ ºÐ¼®À» ÅëÇÕÇÕ´Ï´Ù. ¸ñÇ¥´Â º¸´Ù °³ÀÎȵǰí È¿°úÀûÀÎ Ä¡·á °èȹÀ» °¡´ÉÇÏ°Ô ÇÏ°í ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀΰøÁö´É(AI)ÀÇ ÅëÇÕÀÌ ÁøÇàµÇ°í ÀÖ´Â °ÍÀÌ, ¼¼°è Á¤¹Ð Áø´Ü ½ÃÀåÀÇ È®´ë¸¦ µÞ¹ÞħÇÏ°í ÀÖ½À´Ï´Ù. AI´Â °í±Þ µ¥ÀÌÅÍ ºÐ¼®, ¿¹Ãø ¸ðµ¨¸µ ¹× ¸ÂÃã Ä¡·á °èȹÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á Áø´ÜÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀÔ´Ï´Ù. ÀÌ Çõ½ÅÀº Áúº´ÀÇ Á¶±â ¹ß°ßÀ» °¡¼ÓÈÇÏ°í ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í ¼¼°è °Ç° °ü¸® °üÇàÀ» º¯È½Ãŵ´Ï´Ù.
¾Ï, ½ÉÇ÷°ü Áúȯ, ´ç´¢º´ µî ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡´Â Á¤¹Ð Áø´Ü ¼ö¿ä¸¦ ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. Á¶±â ¹ß°ß°ú °³ÀÎÈµÈ Ä¡·á °èȹÀº ÀÌ·¯ÇÑ Áúº´À» È¿°úÀûÀ¸·Î °ü¸®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ Á¤¹Ð Áø´ÜÀº °³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸Â°Ô Ä¡·á °èȹÀ» Á¶Á¤ÇÏ´Â ¸ÂÃãÇü ÀÇ·á¿¡¼µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº Ä¡·á È¿°ú¸¦ ³ôÀÌ°í ºÎÀÛ¿ëÀ» ÁÙÀ̱â À§ÇØ Á¤¹Ð Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÔ´Ï´Ù. ¶ÇÇÑ Á¤¹Ð Áø´ÜÀÇ ÀÌÁ¡¿¡ ´ëÇÑ °Ç° °ü¸® Àü¹®°¡¿Í ȯÀÚÀÇ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀ̵Ǿú½À´Ï´Ù. ¿©±â¿¡´Â ´õ ³ªÀº Áúº´ °ü¸®, ȯÀÚÀÇ ¿¹ÈÄ °³¼±, Àå±âÀûÀÎ ºñ¿ë Àý°¨ µîÀÌ Æ÷ÇԵ˴ϴÙ. ±×·¯³ª ±ÔÁ¦ ¿ä°ÇÀÌ ¾ö°ÝÇÏ°í Ç¥ÁØÈ°¡ ÁøÇàµÇÁö ¾ÊÀº °ÍÀÌ ¿¹Ãø±â°£ÀÎ 2024-2032³â ¼¼°è Á¤¹Ð Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¤¹Ð Áø´Ü ½ÃÀå Á¶»ç¿¡¼ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÔ´Ï´Ù. 2023³â¿¡´Â ºÏ¹Ì°¡ ¼öÀ͸鿡¼ Áö¹èÀûÀÎ Áö¿ªÀ̾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÁ¡Àº Á¤ºÎ¿Í ¹Î°£ Á¶Á÷ °£ÀÇ ÆÄÆ®³Ê½Ê Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ °ß°íÇÑ °Ç° °ü¸® ÀÎÇÁ¶ó°¡ Áö¿ª ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù. ÀÌ Áö¿ªÀÇ Áß¿äÇÑ ±â¾÷ÀÎ Neuberg Diagnostics Private Limited´Â ¸ÂÃãÇü ÀÇ·á¿¡¼ÀÇ Âü½ÅÇÑ ±â¼ú°ú ¼Ö·ç¼ÇÀ» È°¿ëÇϱâ À§ÇØ ±¹³» ¹× À¯·´¿¡ »õ·Î¿î ÀÎÅ¥º£ÀÌ¼Ç ¼¾Å͸¦ ¼³¸³ÇÏ¿© ±¹³»¿Ü ÁøÃâÀ» È®´ë °èȹÀÔ´Ï´Ù. 2021³â 7¿ù, ȸ»ç´Â ÀεµÀÇ Å׶û°¡³ª ÁÖ¿¡ »õ·Î¿î º´¸® ¿¬±¸¼Ò¸¦ °³¼³Çß½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ´Ù¸¥ ½ÃÀå ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ À¯»çÇÑ ³ë·ÂÀº ÀÌ Áö¿ªÀÇ Àü¸ÁÀ» Å©°Ô °ÈÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø±â°£ÀÎ 2024³âºÎÅÍ 2032³â±îÁö °¡Àå ±Þ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.
Global Precision Diagnostics Market is valued approximately USD 75.85 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 13.10% over the forecast period 2024-2032. Precision diagnostics refers to a field of medical diagnostics that utilizes advanced technologies to precisely identify the specific cause or nature of a patient's disease. This approach tailors diagnostic techniques to the individual characteristics of each patient, often incorporating genetic, molecular, and cellular analysis to achieve a more accurate diagnosis. The goal is to enable more personalized and effective treatment plans, improving patient outcomes. The growing integration of Artificial Intelligence (AI) is driving the expansion of the global precision diagnostics market. AI enhances diagnostic accuracy and efficiency by enabling advanced data analysis, predictive modeling, and personalized treatment plans. This innovation accelerates early disease detection and improves patient outcomes, fueling market growth and transforming healthcare practices worldwide.
The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, and diabetes drives the demand for precision diagnostics. Early detection and personalized treatment plans are crucial in managing these conditions effectively. Also, precision diagnostics play a critical role in personalized medicine, which tailors treatment plans to individual genetic profiles. This approach enhances treatment efficacy and reduces adverse effects, thereby increasing the demand for precision diagnostics. Additionally, increased awareness among healthcare professionals and patients about the benefits of precision diagnostics is driving market growth. This includes better disease management, improved patient outcomes, and cost savings in the long run. However, the stringent regulatory requirements, and lack of standardization are expected to hinder the Global Precision Diagnostics Market growth during the forecast period 2024-2032.
The key regions considered for the Global Precision Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the dominating region in terms of revenue. This dominance is due to the increasing partnerships between government and private organizations. Additionally, a robust healthcare infrastructure will facilitate regional growth. Neuberg Diagnostics Private Limited, a significant player in this region, plans to broaden its domestic and international reach by creating new incubation centers across the country and in Europe to leverage novel technologies and solutions in personalized medicine. In July 2021, the company also opened a new pathology lab in Telangana, India. Comparable initiatives by other market players in the region will significantly enhance the regional outlook in the. Whereas, the Asia Pacific is expected to be the fastest growing region during the forecast period 2024-2032.